216 related articles for article (PubMed ID: 27426982)
21. Identification of IGF-1-enhanced cytokine expressions targeted by miR-181d in glioblastomas via an integrative miRNA/mRNA regulatory network analysis.
Ho KH; Chen PH; Hsi E; Shih CM; Chang WC; Cheng CH; Lin CW; Chen KC
Sci Rep; 2017 Apr; 7(1):732. PubMed ID: 28389653
[TBL] [Abstract][Full Text] [Related]
22. Integrated network analysis reveals distinct regulatory roles of transcription factors and microRNAs.
Guo Y; Alexander K; Clark AG; Grimson A; Yu H
RNA; 2016 Nov; 22(11):1663-1672. PubMed ID: 27604961
[TBL] [Abstract][Full Text] [Related]
23. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.
Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y
Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754
[TBL] [Abstract][Full Text] [Related]
24. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
Dong L; Li Y; Han C; Wang X; She L; Zhang H
Int J Oncol; 2014 Aug; 45(2):746-56. PubMed ID: 24858071
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
26. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
27. Identification of survival‑associated key genes and long non‑coding RNAs in glioblastoma multiforme by weighted gene co‑expression network analysis.
Chen X; Pan C; Xu C; Sun Y; Geng Y; Kong L; Xiao X; Zhao Z; Zhou W; Huang L; Song Y; Zhang L
Int J Mol Med; 2019 Apr; 43(4):1709-1722. PubMed ID: 30816427
[TBL] [Abstract][Full Text] [Related]
28. Analyzing Differential Regulatory Networks Modulated by Continuous-State Genomic Features in Glioblastoma Multiforme.
Chiu YC; Hsiao TH; Wang LJ; Chen Y; Chuang EY
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1754-1764. PubMed ID: 28114032
[TBL] [Abstract][Full Text] [Related]
29. Parameter optimization for constructing competing endogenous RNA regulatory network in glioblastoma multiforme and other cancers.
Chiu YC; Hsiao TH; Chen Y; Chuang EY
BMC Genomics; 2015; 16 Suppl 4(Suppl 4):S1. PubMed ID: 25917195
[TBL] [Abstract][Full Text] [Related]
30. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
31. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
[TBL] [Abstract][Full Text] [Related]
32. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
33. A network-based analysis for mining the risk pathways in glioblastoma.
Li J; Xie Y; Zhang C; Wang J; Wu Y; Yang Y; Xie Y; Lv Z
Oncol Lett; 2019 Sep; 18(3):2712-2717. PubMed ID: 31402957
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.
Bo LJ; Wei B; Li ZH; Wang ZF; Gao Z; Miao Z
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3579-86. PubMed ID: 26502847
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression.
Gao YT; Chen XB; Liu HL
Sci Rep; 2016 Sep; 6():32972. PubMed ID: 27595933
[TBL] [Abstract][Full Text] [Related]
36. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
37. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
38. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
[TBL] [Abstract][Full Text] [Related]
39. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma.
Xu G; Li JY
Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]